Mode
Text Size
Log in / Sign up

Blood neurofilament light chain is associated with poor functional outcomes in patients with ischemic strokeBlood protein levels linked to outcomes after ischemic stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that elevated blood neurofilament light chain is associated with poorer functional outcomes in ischemic stroke.

This meta-analysis evaluated the association between blood neurofilament light chain (NfL) and functional outcomes in a population of 3,448 patients with ischemic stroke. The analysis focused on identifying whether NfL levels could serve as a biomarker for clinical progression.

The primary finding indicates that blood NfL is associated with poor functional outcomes, with a reported odds ratio of 1.78 (95% CI 1.41 to 2.24). Secondary outcomes including area under the curve (AUC), sensitivity, and specificity were also assessed as part of the analysis.

While the association between NfL and poor functional outcomes is statistically significant, the study does not establish a causal link. The evidence is limited by the lack of reported follow-up durations and specific study locations. Clinical application of NfL as a predictive biomarker for ischemic stroke outcomes requires further investigation to establish its specific diagnostic utility and predictive value in clinical practice.

When someone suffers an ischemic stroke, the road to recovery is often uncertain. Doctors look for ways to better predict how well a patient will regain their physical functions. New data suggests that a protein in the blood called neurofilament light chain (NfL) could be a helpful tool for making these predictions.

Researchers looked at data from 3,448 patients who had suffered a stroke. They found that higher levels of this NfL protein were associated with poorer functional outcomes. This means that when the protein levels were high, patients often had more difficulty regaining their normal abilities after the stroke.

While this finding shows a clear link between the protein and recovery, it is important to remember that this is an association, not a direct cause. The study shows that the protein is a marker that might help doctors understand a patient's path, but more information is needed to see how it can change daily care.

What this means for you:
High levels of the NfL protein in the blood are linked to poorer physical recovery after a stroke.

Common questions

What is the NfL protein and how does it relate to stroke?

Neurofilament light chain (NfL) is a protein found in the blood. In this study of 3,448 patients, researchers found that higher levels of this protein were associated with poorer functional outcomes after an ischemic stroke. It serves as a marker that may help doctors understand the severity of the situation.

Can this test tell if a patient will recover fully?

The study shows a link between high NfL levels and poorer outcomes, but it does not prove that the protein causes the outcome. It is an association, meaning the protein is a sign of what might happen, but it is not a guarantee of the final result. Talk to your doctor about what this means for specific cases.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
IntroductionThis meta-analysis aimed to assess the association between blood neurofilament light chain (NfL) and functional outcomes in patients with ischemic stroke.MethodsPubMed, Web of Science, Embase, Cochrane Library, and the China National Knowledge Infrastructure database were searched from inception through March 15, 2026. Odds ratios (ORs) and 95% confidence intervals (CIs) were pooled to quantify the association between blood NfL and functional outcomes in patients with ischemic stroke. We pooled the area under the curve (AUC), sensitivity, and specificity; conducted meta-regression and sensitivity analyses; and assessed publication bias.ResultsA total of 18 studies involving 3,448 patients were included in this meta-analysis. The pooled results demonstrated that blood NfL was associated with poor functional outcomes after ischemic stroke (OR = 1.78, 95% CI: 1.41–2.24, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.